Drug-eluting stent use with abbreviated dual antiplatelet therapy after percutaneous coronary intervention for liver transplantation evaluation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug-eluting stent use with abbreviated dual antiplatelet therapy after percutaneous coronary intervention for liver transplantation evaluation

Published:2023-02-07 Issue:4 Volume:29 Page:459-462
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:

Author:

Koshy Anoop N.¹²,Sampaio Rodrigues Thalys¹²,Gow Paul J.²³,Cailes Benjamin¹,VanWagner Lisa B.⁴,Farouque Omar¹²

Affiliation:

1. Department of Cardiology, Austin Health, Melbourne, Victoria, Australia

2. The University of Melbourne, Parkville, Victoria, Australia

3. Victorian Liver Transplant Unit, Austin Hospital, Melbourne, Victoria, Australia

4. Department of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Centre, Dallas, Texas, USA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation,Hepatology,Surgery

Reference5 articles.

1. Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: an evaluation of the evidence and consensus recommendations;VanWagner;Am J Transplant,2018

2. Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials;Piccolo;Lancet,2019

3. Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI;Valgimigli;J Am Coll Cardiol,2021

4. Cardiac risk stratification in liver transplantation: results of a tiered assessment protocol based on traditional cardiovascular risk factors;Robertson;Liver Transpl,2021

5. A prospective natural history study of coronary atherosclerosis following liver transplantation;Koshy;Atherosclerosis,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease assessment and management in liver transplantation;European Heart Journal;2024-08-17

2. Management of the liver transplant candidate with high cardiac risk: Multidisciplinary best practices and recommendations;Liver Transplantation;2024-05-13

3. Enhancing pre-transplant cardiac assessment: Validation and utility of the CAD-LT score with CCTA in liver transplant candidates;International Journal of Cardiology;2024-05

4. CACS, CCTA and mCAD‐LT score in the pre‐transplant assessment of coronary artery disease and the prediction of post‐transplant cardiovascular events;Liver International;2024-04-09

5. Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?;Liver Transplantation;2024-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3